CellCare

Cell Care is Australia's leading cord blood and tissue bank, providing families with specialized stem cell collection and long-term storage services. The company operates a state-of-the-art laboratory in Melbourne and has expanded its international footprint through the acquisition of Canada's Insception Lifebank. Beyond its core banking operations, Cell Care is a significant player in the regenerative medicine sector, actively funding and participating in clinical trials for conditions such as cerebral palsy, type 1 diabetes, and hypoxic-ischemic encephalopathy. In 2021, Cell Care was acquired by Generate Life Sciences, which was subsequently acquired by CooperSurgical, a division of the publicly traded CooperCompanies. This integration has positioned Cell Care as part of a global platform dedicated to advancing newborn stem cell research and reproductive health.